EIKN
Eikon Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$11.46
-0.32 ▼ -2.72%
🌙 3월 13일 7:13 PM ET (한국 3/14 08:13)
$11.47
+0.01 ▲ +0.09%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 44.61% | Shs Outstand | 0.05B | Perf Week | -20.31% |
| Market Cap | 0.62B | Forward P/E | - | EPS next Y | 8.48% | Insider Trans | 13.34% | Shs Float | 0.03B | Perf Month | -20.91% |
| Enterprise Value | 1.41B | PEG | - | EPS next Q | -1.61 | Inst Own | 5.21% | Short Float | 5.32% | Perf Quarter | - |
| Income | - | P/S | - | EPS this Y | 38.9% | Inst Trans | 0.05% | Short Ratio | 2.83 | Perf Half Y | - |
| Sales | - | P/B | - | EPS next 5Y | 20.97% | ROA | - | Short Interest | 1.59M | Perf YTD | -23.6% |
| Book/sh | -11.34 | P/C | 2.81 | EPS past 3/5Y | - | ROE | - | 52W High | -34.14% ($17.40) | Perf Year | - |
| Cash/sh | 4.08 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | -0.35% ($11.50) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 12.88% 10.4% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.57 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.04 | EPS Q/Q | - | Profit Margin | - | RSI (14) | 34.4 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.04 | Sales Q/Q | - | SMA20 | -20.19% ($14.36) | Beta | - | Target Price | $25.6 |
| Payout | - | Debt/Eq | 0.86 | Earnings | 2026/02/25 | SMA50 | -20.37% ($14.39) | Rel Volume | 0.89 | Prev Close | $11.78 |
| Employees | - | LT Debt/Eq | 0.82 | EPS/Sales Surpr. | - | SMA200 | -20.37% ($14.39) | Avg Volume(3M) | 0.56M | Price | $11.46 |
| IPO | 2026/2/5 | Option/Short | No/Yes | Trades | 4412 | Volume | 500,936 | Change | -2.72% |
뉴스 로딩 중...